US FDA orders new eye risk warnings for Ozempic, Zepbound

US FDA orders new eye risk warnings for Ozempic, Zepbound

来源:Reuters发布于 2026-11-09

The US FDA ​on Monday informed patients ‌and healthcare providers of a potential increased risk of ​a serious eye condition ​associated with the use ⁠of GLP-1 drugs used ​for weight loss and ​diabetes...

相关标的:LLYNVO

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。